The share of U.S. scientific publications in the top 10% of citations within molecular biology has been forecasted to remain stable at 12.7% from 2024 through 2028. This indicates no year-on-year growth in this metric through the five-year period. The stability since 2023 suggests that the U.S.'s contribution to highly-cited work in this field is steady, with no significant shifts expected in the near term.
Looking ahead, future trends to watch for include advancements in biotechnology that might alter publication focus areas, potential increases in international collaboration, and evolving citation practices that could impact the emphasis on high-impact publications.
